Jervell and Lange-Nielsen Syndrome due to a Novel Compound Heterozygous KCNQ1 Mutation in a Chinese Family.,Neural Plasticity

当前位置： X-MOL 学术 › Neural Plast. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Jervell and Lange-Nielsen Syndrome due to a Novel Compound Heterozygous KCNQ1 Mutation in a Chinese Family.
Neural Plasticity ( IF 3.0 ) Pub Date : 2020-05-16 , DOI: 10.1155/2020/3569359
Yue Qiu ₁ , Sen Chen ₁ , Xia Wu ₁ , Wen-Juan Zhang ₂ , Wen Xie ₁ , Yuan Jin ₁ , Le Xie ₁ , Kai Xu ₁ , Xue Bai ₁ , Hui-Min Zhang ₁ , Xiao-Zhou Liu ₁ , Xiao-Hui Wang ₁ , Yu Sun ₁ , Wei-Jia Kong _{1,

3}

Affiliation

Jervell and Lange-Nielsen syndrome (JLNS) is a rare but severe autosomal recessive disease characterized by profound congenital deafness and a prolonged QTc interval (greater than 500 milliseconds) in the ECG waveforms. The prevalence of JLNS is about 1/1000000 to 1/200000 around the world. However, exceed 25% of JLNS patients suffered sudden cardiac death with kinds of triggers containing anesthesia. Approximately 90% of JLNS cases are caused by KCNQ1 gene mutations. Here, using next-generation sequencing (NGS), we identified a compound heterozygosity for two mutations c.1741A>T (novel) and c.477+5G>A (known) in KCNQ1 gene as the possible pathogenic cause of JLNS, which suggested a high risk of cardiac events in a deaf child. The hearing of this patient improved significantly with the help of cochlear implantation (CI). But life-threatening arrhythmias occurred with a trigger of anesthesia after the end of the CI surgery. Our findings extend the KCNQ1 gene mutation spectrum and contribute to the management of deaf children diagnosed with JLNS for otolaryngologists (especially cochlear implant teams).

更新日期：2020-05-16

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11